Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01682837 · ClinicalTrials.gov registry record · Phase 2
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT01682837 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 35 participants.
The verdict
NCT01682837, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.
Interventions
- DRUG Placebo
- DRUG Potassium chloride powder
- DRUG Potassium citrate powder
- DRUG Potassium magnesium citrate powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01682837
The ClinicalTrials.gov registry entry for NCT01682837 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01682837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01682837 about?
NCT01682837 is a clinical study titled "Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension". Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.
What is the current status of trial NCT01682837?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2012-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01682837?
The interventions under investigation include: Placebo (DRUG), Potassium chloride powder (DRUG), Potassium citrate powder (DRUG), Potassium magnesium citrate powder (DRUG).
Who is sponsoring clinical trial NCT01682837?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.